Announcement

Collapse
No announcement yet.

iScience . Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
Working...
X